Peptides News and Research

RSS

Movies help explain how proteins gather into clusters called amyloid fibrils

To get a better look at how proteins gather into clusters called amyloid fibrils – which are associated with important human diseases such as Alzheimer’s, Parkinson’s and the so-called prion diseases like Mad Cow – researchers at North Carolina State University decided to make movies.

23 Nov 2004

Transport route explain why peanuts are one of the most allergenic foods

A UK scientist has discovered the route and type of transport taken by peanut proteins through the gut to the immune system. This route favours an immune response, which helps explain why peanuts are one of the most allergenic foods.

18 Nov 2004

New test for heart surgery patients

Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.

11 Nov 2004

Link between immune protein and longer survival in melanoma patients

Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.

5 Nov 2004

Study reveals anti-arthritic effects of bee venom

Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.

4 Nov 2004

Reproductive hormones have effects on all of these stages of brain growth and development

Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.

2 Nov 2004

New clues about how brain cells are damaged by Alzheimer's disease

University of Kentucky chemistry professor Allan Butterfield has uncovered new clues about how brain cells are damaged by Alzheimer's disease, evidence suggesting vitamin E may help prevent the debilitating illness.

1 Nov 2004

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

A potential new therapeutic approach to Alzheimer's disease protects brain cells in culture by drastically reducing the neurotoxic amyloid protein aggregates that are critical to the development of the disease.

29 Oct 2004

New insights into hormone therapy show when estrogen best aids brain

New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells—most of which can alleviate some of the cognitive decline associated with menopause.

28 Oct 2004

Easy-to-make vaccine tackles a range of illnesses

Australian researchers have created a totally synthetic vaccine that is effective against viruses, harmful bacteria and tumours and could lead to a powerful new arsenal of vaccines for humans and animals.

26 Oct 2004

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.

26 Oct 2004

Discovery might improve design, effectiveness of anti-cancer drugs

Working with an enzyme that degrades anti-cancer drugs in humans, University of North Carolina at Chapel Hill biochemists and colleagues have made a discovery that they believe eventually could help improve such drugs’ design and effectiveness.

18 Oct 2004

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant from the National Institutes of Health in the USA to develop a vaccine against Group A streptococcus. This extremely prestigious grant makes QIMR one of the most successful recipients of NIH funding in Australia.

18 Oct 2004

Transparent gel could soon become the first and best choice for sealing corneal incisions

The substance, known as a hydrogel, promises to be a useful tool in the kit used for the most common of ophthalmic surgeries: cataract removal. Currently, 11 million such surgeries are performed worldwide annually, a figure expected to increase as the world's population grows older.

12 Oct 2004

Bandage that uses peptides and collagen, capable of healing wounds and regenerating tissue

Hapto-Biotech, an Israeli start-up company, and New York-based Ortec International Inc., have joined forces to develop a bandage capable of healing wounds and regenerating tissue, using a unique combination of peptides and collagen.

12 Oct 2004

Carbon nanotubes offer a new approach to gene therapy

Many genes that are related to particular diseases have now been identified. Scientists are trying to use this knowledge to treat diseases.

11 Oct 2004

First use of technology called ubiquitin-mediated fluorescence complementation to study a cell-signaling mechanism called ubiquitination

Researchers at the University of Michigan Medical School and Howard Hughes Medical Institute have found a way to see proteins in cells that have been tagged by a molecular “sticky note” called ubiquitin.

8 Oct 2004

The search for the Holy Grail for dieters is on

Starting this month Canadian and British scientists will begin collaborating on a study to examine human appetite- controlling hormones with a view to finding out what will increase PYY, a powerful hormone in the human body which dramatically diminishes appetite.

7 Oct 2004

$10 million to establish a multidisciplinary research program in cancer nanotechnology

The National Institutes of Health (NIH) has awarded scientists from Emory University and the Georgia Institute of Technology two new collaborative research grants, totaling nearly $10 million, to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

6 Oct 2004

$Analysis shows Teriparatide reduces fracture risk independent of bone turnover$

Analysis shows Teriparatide reduces fracture risk independent of bone turnover

Data presented yesterday at the 26th annual meeting of the American Society for Bone and Mineral Research (ASBMR) show that the ability of teriparatide to prevent fractures remained consistent regardless of pretreatment bone turnover status.

5 Oct 2004